Literature DB >> 21700699

Dermabond decreases pericatheter local anesthetic leakage after continuous perineural infusions.

Harshad Gurnaney, F Wickham Kraemer, Arjunan Ganesh.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21700699     DOI: 10.1213/ANE.0b013e31821d38fb

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  5 in total

1.  Fascia iliaca compartment block: How far does the local anaesthetic spread and is a real time continuous technique feasible in children?

Authors:  Vrushali C Ponde; Anuya A Gursale; Dilip N Chavan; Ashok N Johari; Maryrose O Osazuwa; Tripti Nagdev
Journal:  Indian J Anaesth       Date:  2019-11-08

2.  Decreasing leakage during continuous femoral nerve catheter fixation using 2-octyl cyanoacrylate glue (Dermabond®): a randomized controlled trial.

Authors:  Theerawat Chalacheewa; Vanlapa Arnuntasupakul; Lisa Sangkum; Rungrawan Buachai; Jiravud Chanvitayapongs
Journal:  BMC Anesthesiol       Date:  2021-06-11       Impact factor: 2.217

3.  Comparison of catheter-over-needle and catheter-through-needle methods in ultrasound-guided continuous femoral nerve block: A prospective, randomized controlled trial.

Authors:  Hee Young Kim; Ji-Soo Ahn; Seyeon Park; Eun-Ji Choi; Hyun-Su Ri; Ji-Uk Yoon; Gyeong-Jo Byeon
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

4.  Adverse events associated with continuous interscalene block administered using the catheter-over-needle method: a retrospective analysis.

Authors:  Meishu Tanijima; Kenichi Takechi; Kazuo Nakanishi; Toshihiro Yorozuya
Journal:  BMC Anesthesiol       Date:  2019-10-28       Impact factor: 2.217

5.  Effectiveness of securing central venous catheters with topical tissue adhesive in patients undergoing cardiac surgery: a randomized controlled pilot study.

Authors:  Naruemol Prachanpanich; Sunthiti Morakul; Napanont Kiatmongkolkul
Journal:  BMC Anesthesiol       Date:  2021-03-08       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.